In Q1 2003 Deep Life Group commenced development of a true anti-viral mask for hospital and public use, in response to SARS-CoV-1 outbreak. The development took 6 years, including development of some of the key technology within the University of Dundee. By the time the technology had been developed into the AVM mask, the SARS-CoV-1 outbreak was history and the technology lay on the shelf.
In 2020 we formed the business and acquired the Deep Life Group technology.
Contagion Controls are investing in the AVM mask to address the need for superior protection for medical staff and care workers that give them confidence that they are totally protected whilst wearing it.
The technology is novel, using an electrostatic filter that pulls even the smallest particles from the inhaled or exhaled gas, into a molecular sieve, where it neutralises them using the same nano-silver coatings that provides the electrostatic field. The mask has a soft silicone oro-nasal seal, is comfortable to wear all day, and has a pleasant appearance.
Contagion Controls complement this by providing conventional masks and protective clothing, all made in Europe, with open book source to end user pricing, to enable end users to access all the PPE required to deal with viral outbreaks, at the lowest possible pricing.
All rights are owned by Contagion Controls ltd and patents are pending.
Contagion Controls ltd specialise in masks and viral protection systems using technology to offer new products that are designed to protect medical staff from infection. We also supply a standard range of PPE and have a range of manufacturing sources across the word.
We are ISO 9001:2015 certified for the design of hardware and related software, and the protection of intellectual property. We operate an Environmental Management System which covers all our processes and is ISO 14001:2015 certified. Our design centres and processes are shared with Deep Life Group, with safety design processes have been certified to comply with EN 61508 to SIL 3 (a very onerous level) for life support applications.
For further information on our partners or our technologies, contact: firstname.lastname@example.org